3.Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
International Journal of Arrhythmia 2017;18(3):148-150
No abstract available.
Atrial Fibrillation*
;
Dabigatran*
;
Warfarin*
4.Is Lighter Intensity of Warfarin Therapy Enough for Korean Patients with Non-Valvular Atrial Fibrillation?
Korean Circulation Journal 2020;50(2):176-178
No abstract available.
Atrial Fibrillation
;
Humans
;
Warfarin
6.Successful Treatment of Livedoid Vasculitis with Primary Antiphospholipid Syndrome by Using Aspirin and Low Dose Warfarin Combination Therapy.
Byoung Joon SO ; Jae Beom PARK ; Min Gun YOO ; Il Hwan KIM ; Sang Wook SON
Annals of Dermatology 2015;27(5):614-615
No abstract available.
Antiphospholipid Syndrome*
;
Aspirin*
;
Vasculitis*
;
Warfarin*
7.Successful Treatment of Livedoid Vasculitis with Primary Antiphospholipid Syndrome by Using Aspirin and Low Dose Warfarin Combination Therapy.
Byoung Joon SO ; Jae Beom PARK ; Min Gun YOO ; Il Hwan KIM ; Sang Wook SON
Annals of Dermatology 2015;27(5):614-615
No abstract available.
Antiphospholipid Syndrome*
;
Aspirin*
;
Vasculitis*
;
Warfarin*
8.Priapism Associated with the Discontinuation of Oral Wafarin.
Mi Ho SONG ; Seung Whan DU ; Won Jae YANG ; Yun Seob SONG
Korean Journal of Andrology 2010;28(2):141-143
Priapism attributable to an anticoagulant drug has rarely been reported. Although the pathophysiology of this type of priapism is not well understood, most investigators contend that thromboembolic phenomena play either a causative or supportive role. We describe a case of priapism associated with the discontinuation of oral warfarin.
Heparin
;
Humans
;
Priapism
;
Research Personnel
;
Warfarin
9.Management of Antithrombotic Therapy for Gastroenterological Endoscopy from a Cardio-Cerebrovascular Physician's Point of View.
Clinical Endoscopy 2014;47(4):320-323
Periprocedural management of antithrombotics for gastroenterological endoscopy is a common clinical issue. To decide how to manage the use of antithrombotics in patients undergoing endoscopy, the risk for hemorrhage and thromboembolism during the procedure must be considered. For low-risk procedures, no adjustments in antithrombotics are needed. For high-risk procedures with a low thromboembolic risk, discontinuation of warfarin at 5 days, and clopidogrel at 5 to 7 days before the procedure has been recommended. However, it is better to continue aspirin use even during high-risk procedures. A heparin bridging therapy may be considered before endoscopy in patients with a high thromboembolic risk. The management of patients taking antithrombotics remains complex, especially in high-risk settings.
Aspirin
;
Endoscopy*
;
Hemorrhage
;
Heparin
;
Humans
;
Thromboembolism
;
Warfarin
10.New Oral Anticoagulants versus Warfarin for Cerebral Venous Thrombosis: A Multi-Center, Observational Study
Mohammad WASAY ; Maria KHAN ; Haris Majid RAJPUT ; Salman FAROOQ ; Mohammed Ibrahim MEMON ; Suhail Abdulla ALRUKN ; Abdul MALIK ; Foad ABD-ALLAH ; Raja Farhat SHOAIB ; Rizwana SHAHID ; Sadia NISHAT ; Safia AWAN
Journal of Stroke 2019;21(2):220-223
No abstract available.
Anticoagulants
;
Observational Study
;
Venous Thrombosis
;
Warfarin
Result Analysis
Print
Save
E-mail